Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Connecticut · 2025 Regular Session · Bill

SB 1473: AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

Enacted Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 1473 is a bill introduced in the Connecticut Senate on March 6, 2025. According to its official title, it concerns: AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE. Most recent recorded action (June 23, 2025): SIGNED BY GOVERNOR.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

NameRolePartyChamberDistrict
No sponsor recorded in source data.

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. SIGNED BY GOVERNOR
  2. TRANSMITTED BY SECRETARY OF THE STATE TO GOVERNOR
  3. TRANSMITTED TO SECRETARY OF THE STATE
  4. PUBLIC ACT 25-63
  5. IN CONCURRENCE
  6. HOUSE PASSED
  7. HOUSE CALENDAR NUMBER 526
  8. FAV. RPT., TABLED FOR HOUSE CALENDAR
  9. SENATE PASSED
  10. FILE NO. 384
  11. SENATE CALENDAR NUMBER 235
  12. FAV. RPT., TAB. FOR CAL., SEN.

Showing 12 most recent of 18 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source